Dale Broadrick bought $18k of BRTX
owner at BioRestorative Therapies, Inc.. 6,200 shares at an average of $2.86, traded Nov 30, 2022, filed Mar 3, 2023.
Score components
- +12Role10% owner
- 0Trade size$18k at market
- 0Relative to holdingsHoldings up 2.1%
- +8Price context49% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001567619-23-004348, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 30, 2022 | POpen-market purchase Common Stock | +100 | $2.78 | $278 | 298,973 | Mar 3, 2023 |
| Nov 30, 2022 | POpen-market purchase Common Stock | +100 | $2.77 | $277 | 299,073 | Mar 3, 2023 |
| Feb 22, 2023 | POpen-market purchase Common Stock | +5,000 | $2.84 | $14k | 304,073 | Mar 3, 2023 |
| Feb 22, 2023 | POpen-market purchase Common Stock | +1,000 | $2.95 | $2,950 | 305,073 | Mar 3, 2023 |
Related signals
Other insiders at BioRestorative Therapies, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | Dale Broadrick owner | $1,757 1,112 shares | -0% | |
| 36Weak | BRTXbuy BioRestorative Therapies, Inc. | Francisco Silva VP of Research and Development | $10k 8,308 shares | +6% | |
| 52Moderate | BRTXbuy BioRestorative Therapies, Inc. | Dale Broadrick owner | $206k 160,000 shares | +50% | |
| 42Moderate | BRTXbuy BioRestorative Therapies, Inc. | Dale Broadrick owner | $162k 120,000 shares | +37% | |
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | Dale Broadrick owner | $469 250 shares | -0% | |
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | Dale Broadrick owner | $525 278 shares | -0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $1,241 400 shares | +0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $602 200 shares | +0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $627 200 shares | +0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $1,244 400 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.